International Journal of Inflammation

Research Article

High Vitamin D Levels May Downregulate Inflammation in Patients with Behçet’s Disease

Table 2

Patients’ clinical characteristics, treatment, and their vitamin D status.
NumberGAgeOAGUOICIPPVIGIENTDA 25(OH)DESR CRP
1F33++−+−−−+−766<5
2M51+++++−++−7177
3F35++−+−−−+A42255
4F23++−+−−−+−4511<5
5F17++++−−−−−506<5
6M48++++−+−−−6512<5
7M56+−++−−−+−582<5
8F37++−+−−−−−6712<5
9F38++−−+−−−−418<5
10M34++−+−−−−−7617<5
11F37++−+−−−−−335<5
12F52++−+−+−−A2828<5
13F81 + + + + − − − −−4114<5
14F66 + + − + − − + −−3533<5
15M45 + + − − − + − −−297<5
16F37 + + − + − − − −A212825
17F23 + + + + − − − −−535<5
18F21 + + − + − − − −−2613<5
19F24 + + − + − − − −A4914<5
G: gender; OA: oral aphthosis; GU: genital ulcers; OI: ocular involvement; CI: cutaneous involvement; PP: pathergy phenomenon; VI: vascular involvement; GI: gastrointestinal involvement; ENT: otolaryngeal involvement; DA: disease activity; A: active disease; 25(OH)D: 25-hydroxyvitamin D (nmol/L); ESR: erythrocyte sedimentation rate (mm/hour); CRP: C-reactive protein (mg/L).